Literature DB >> 222458

Multiple 5' terminal cap structures in late polyoma virus RNA.

A J Flavell, A Cowie, S Legon, R Kamen.   

Abstract

Nuclear and cytoplasmic polyoma virus-specific RNA extracted from 32P-labeled mouse embryo cells late during productive viral infection was analyzed for the presence of 5' terminal capped structures by complete digestion with RNAases T1, T2 and A, followed by two-dimensional electrophoretic fractionation. Seven major cap I structures (m7 GpppNm1pN2p) were observed in both cases. These termini were further characterized by digestion with penicillium nuclease P1, followed by product analysis in a variety of alternative separate systems. Each structure had an individual combination of N1 and N2 nucleotides, where N1 was always a purine nucleotide but N2 was any nucleotide subject to the single exception that m7GpppGmpCp is found only in low yield. Four different cap II derivatives (m7GpppNm1pNm2pN3p) of four of the cap I structures were also detected in cytoplasmic RNA. None of the termini described derived from contaminating host cell RNA. All of these cap structures mapped on the polyoma viral DNA genome between 66 and 71 map units, a region distant from the 5' end of the bodies of two of the three late polyoma mRNAs. All the polyoma virus-specific cap structures, however, were present in each of the purified 16S, 18S and 19s late mRNAs. These data suggested that families of capped leader sequences of varying sizes are attached to the main body of each late polyoma mRNA species by a splicing mechanism.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 222458     DOI: 10.1016/0092-8674(79)90012-6

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  40 in total

1.  Construction and analysis of viable deletion mutants of polyoma virus.

Authors:  G Magnusson; P Berg
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

2.  Heterogeneity of the 5' terminus of late mRNA induced by a viable simian virus 40 deletion mutant.

Authors:  G Haegeman; H van Heuverswyn; D Gheysen; W Fiers
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

3.  The Drosophila melanogaster actin 5C gene uses two transcription initiation sites and three polyadenylation sites to express multiple mRNA species.

Authors:  B J Bond; N Davidson
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

4.  Replication-dependent transactivation of the polyomavirus late promoter.

Authors:  K B Cahill; A J Roome; G G Carmichael
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

5.  Polyomavirus late leader region serves an essential spacer function necessary for viability and late gene expression.

Authors:  G R Adami; G G Carmichael
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

6.  Polyoma virus DNA: Sequence from the late region that specifies the leader sequence for late mRNA and codes for VP2, VP3, and the N-terminus of VP1.

Authors:  J R Arrand; E Soeda; J E Walsh; N Smolar; B E Griffin
Journal:  J Virol       Date:  1980-02       Impact factor: 5.103

7.  Localization of three major cappe 5' ends of polyoma virus late mRNA's within a single tetranucleotide sequence in the viral genome.

Authors:  A J Flavell; A Cowie; J R Arrand; R Kamen
Journal:  J Virol       Date:  1980-02       Impact factor: 5.103

8.  Characterisation of polyoma late mRNA leader sequences by molecular cloning and DNA sequence analysis.

Authors:  R Treisman
Journal:  Nucleic Acids Res       Date:  1980-11-11       Impact factor: 16.971

9.  The genome of minute virus of mice, an autonomous parvovirus, encodes two overlapping transcription units.

Authors:  D Pintel; D Dadachanji; C R Astell; D C Ward
Journal:  Nucleic Acids Res       Date:  1983-02-25       Impact factor: 16.971

10.  Nucleotide sequences and mapping of novel heterogenous 5'-termini of adenovirus 2 early region 4 mRNA.

Authors:  S Hashimoto; M H Pursley; M Green
Journal:  Nucleic Acids Res       Date:  1981-04-10       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.